BioAge Labs, Inc. (BIOA) is deemed a strong investment opportunity with a price target of $7

From Yahoo Finance: 2025-04-21 13:02:00

BioAge Labs, Inc. (BIOA) is the focus of a bullish thesis by Ragnarok Research. Shares were trading at $3.87 as of April 17th. Following a sharp decline after halting a clinical trial, the company still holds significant value. With a price target of $7 per share, BioAge Labs is considered a strong investment opportunity.

Despite not being among the 30 Most Popular Stocks Among Hedge Funds, 13 hedge fund portfolios held BIOA at the end of the fourth quarter. While the company carries risk, there are other AI stocks with greater potential for higher returns in a shorter timeframe. Investors seeking a promising AI stock trading at less than 5 times earnings can explore other options.



Read more at Yahoo Finance: BioAge Labs, Inc. (BIOA): A Bull Case Theory